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Epidurals for liver transplantation – Where are we?
Abstract
Thoracic epidural analgesia (TEA) has been used as a mode of postoper-
ative pain relief for orthotopic liver transplants (OLT) in a selected group of
patients. It is not widely practiced in view of the impaired haemostasis asso-
ciated with end-stage liver disease and severe unpredictable intraoperative
coagulopathy. TEA in OLT may not be the technique of choice for routine
administration of postoperative analgesia, but can be considered in patients
who have a normal coagulation profile preoperatively. Safe conduct of
TEA in OLT involves anaesthetic expertise and stringent monitoring in the
postoperative period. This review discusses the status of thoracic epidural
analgesia in patients undergoing an orthotopic liver transplant.
INTRODUCTION
Orthotopic liver transplantation (OLT) is now an established treat-ment for end-stage liver disease. A successful outcome is largely
dependent on a multidisciplinary approach in the perioperative man-
agement of a liver transplant (LT) recipient. The anaesthetist forms a
very important part of this team and contributes significantly not only
to intraoperative management, but to postoperative care as well. Provi-
sion of postoperative analgesia forms an important part of postoperative
care for an LT recipient.
Thoracic epidural analgesia (TEA) provides the most efficient peri-
and postoperative analgesia following major abdominal surgery, which
includes liver resection and living donor hepatectomy (1–4). It also de-
creases postoperative morbidity and mortality (5). However, its use is
not popular in patients with end-stage liver disease (6, 7). This is
mainly due to concerns regarding an epidural haematoma due to a
grossly deranged coagulation profile in this patient population and
rapid changes in intra- and postoperative coagulation related to fre-
quently unpredictable liver dysfunction. Thoracic epidurals as a mode
of postoperative analgesia in LT recipients are not only challenging but
controversial as well. In this review, we attempt to discuss the current
status of epidural anaesthesia and analgesia in LT surgery.
Intensity of pain in LT recipients
Considering that an LT is the biggest of major abdominal operations
in terms of duration, stress for the patient and the surgical team in-
volved, and the size of the surgical subcostal incision, it is logical to ex-
pect that the postoperative pain is the most intense of all major abdomi-
nal operations.
Indeed, the surgery is performed via a large, bilateral subcostal inci-
sion extending from the cephalad to the xiphoid process, commonly re-
ferred to as the 'Mercedes-Benz incision'. A bilateral subcostal incision
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means that breathing and coughing will augment the al-
ready intense postoperative pain in this group of patients
(6). Furthermore, surgical equipment that keeps the al-
ready large incision wide open for a long intraoperative
period further contributes to intense intra- and postoper-
ative pain.
However, nociceptive pain is most intense during the
dissection phase, during which the enlarged liver has to
be often separated from the surrounding structures. Once
the native liver is removed, nociceptive pain decreases
because the donor liver has no nerve connections with
the recipient. The new liver is usually smaller than the
native liver, and the pain caused by abdominal distension
from ascitic fluid and an enlarged native liver in an LT
recipient becomes less intense following donor liver im-
plantation.
In addition, metabolism of all pain relief medication
is affected by the pre-reperfusion, non-functioning liver.
Following reperfusion of the donor liver, metabolism of
analgesics improves significantly if the donor liver is
working well.
There is a common sentiment among anaesthetists
that OLT recipients need less analgesia than patients
who undergo other major abdominal surgery. This view-
point has not been confirmed in the literature. Only 1
study has reported that OLT patients experience less
pain and require a lower dose of morphine postopera-
tively than liver resection patients do (8). From our clini-
cal experience, we know that LT patients can suffer from
severe pain because of the large surgical incision in the
upper abdominal region, and they may require large
amounts of opiates in the postoperative period.
Epidural Analgesia – Why should it be
used?
The aim of an effective analgesic regime is to provide
patient comfort by preventing postoperative pain, but at
the same time avoiding the adverse effects of analgesic
agents. Epidural analgesia fulfils most of the above crite-
ria, and is therefore the gold standard of postoperative
analgesia. TEA is the most common mode of analgesia
in major abdominal surgery. As TEA reduces systemic
narcotic requirements, it is associated with less postoper-
ative sedation, better postoperative bowel function, better
preservation of pulmonary function through easier pul-
monary toilet, and earlier ambulation (9, 10). Meta-anal-
ysis of randomised controlled trials on the influence of
different anaesthetic and postoperative analgesic regi-
mens on pulmonary outcome found that thoracic epi-
dural anaesthesia and analgesia using opioids and local
anaesthetics was associated with a decreased incidence of
atelectasis, pulmonary infections, and hypoxaemia as
compared with systemic opioids (11). On the other hand,
another study evaluating subgroup analyses to identify
specific types of patients who may have benefited from
epidural analgesia in a large trial (9) found no difference
in the outcome between epidural and control groups in
subgroups at increased risk of respiratory or cardiac com-
plications. No differences were found in the length of
stay in intensive care or in the hospital. The authors
found no evidence that perioperative epidural analgesia
significantly influences major morbidity or mortality fol-
lowing major abdominal surgery (12).
As none of these trials included LT recipients, it is safe
to assume that even though TEA provides optimal pain
management in upper abdominal and thoracic surgery,
its effect on postoperative complications and outcome
benefits as compared to intravenous analgesia in LT sur-
gery needs further evaluation.
Despite severe postoperative pain and the advantages
of TEA described above, most centres practice the use of
intravenous patient-controlled analgesia (IV-PCA) for
postoperative pain control in LT recipients (6). In the
subsequent text, we will discuss controversies related to
epidural analgesia in LT patients.
TEA in OLT – The Controversies
Patients awaiting liver transplantation frequently have
a deranged coagulation profile associated with end-stage
liver disease. The coagulopathy is a result of impaired
synthesis of clotting factors, thrombocytopenia, and pla-
telet dysfunction (13). Prolonged international normal-
ized ratio (INR), prothrombin time (PT), partial trom-
boplastin time (aPTT), and thrombocytopenia are com-
mon findings on the day of surgery in LT recipients.
Massive surgical bleeding can further deteriorate coagu-
lopathy. A prolonged anhepatic phase can lead to fibri-
nolysis. Coagulopathy can follow an unpredictable cour-
se in the post-reperfusion phase (14). Use of a bypass with
heparin-coated bypass lines and/or release of heparin-
-like substances from the donor liver can contribute to
further deterioration of clotting.
Postoperatively, coagulation factor levels and platelet
count increase steadily toward normal values in the pres-
ence of a normally functioning graft (15). With such de-
ranged blood clotting, an epidural haematoma, a cata-
strophic complication of epidural catheterisation, is the
worst fear of every LT anaesthetist. A study from Sweden
suggests that the frequency of hematoma is 1.3–2.7 per
100,000 neuraxial anaesthetics (16). The risk is probably
increased in patients with impaired haemostasis due to
coagulopathy, which is frequently present in LT recipi-
ents, or therapeutic anticoagulation, also present in LT
recipients, as antithrombotic drugs are used to prevent
hepatic artery thrombosis and deep venous thrombosis
(17). There is also a concern for local anaesthetic toxicity
as the amides in local anaesthetics are metabolised in the
liver. In a recent study, patients who received TEA for
liver resection revealed significantly higher levobupiva-
caine concentrations as compared to patients undergoing
anterior rectal resection (18). This should be kept in
mind with patients whose graft does not function opti-
mally in the postoperative period.
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TEA in OLT – The evidence so far
Although we are aware that TEA has been used for
postoperative analgesia in a small proportion of LT re-
cipients, there is very limited evidence in the literature
regarding the use of TEA in OLT. By searching the liter-
ature, we found only 1 retrospective study published re-
cently, several case reports, 1 abstract presented at a Liver
Intensive Care Group of Europe (LiCAGE) meeting,
and an extensive exchange of opinions on the topic on
the LiCAGE website.
Case reports are related to the paediatric LT popula-
tion, where fast tracking was recently introduced with
great benefit to LT recipients (19). Diaz et al. described
the first successful use of thoracic epidural anaesthesia as
an adjunct for peri- and postoperative analgesia in paedi-
atric liver transplantation (20). An epidural catheter was
inserted at the T8-T9 level after induction of anaesthesia.
The authors injected the anaesthetic solution, which
consisted of 10 mL of 0.2% ropivacaine with 45 mg of
clonidine and 300 mg of morphine, before removing the
catheter. The child could be extubated on the table and
did not require any analgesic drug during the first 24 h
(20). Kim and Harbbot reported the use of caudal epi-
dural anaesthesia in a paediatric liver transplant. They
used single-shot morphine without a local anaesthetic
due to concerns for intraoperative hypotension. The child
could be extubated on the table and remained pain free
for the next 6 h (21).
In 2010, Trezebicki and colleagues published the sin-
gle largest study on the use of TEA in OLT (22). The au-
thors described their 10-year experience in the use of
TEA in 67 patients undergoing OLT. TEA was per-
formed by experienced anaesthetists in patients with
INR < 1.5, APTT < 45 s, platelets > 70 G/L, and a nor-
mal thromboelastogram (22). The authors assessed extu-
bation time, frequency of complications, and undesired
accidents. From 279 patients undergoing LT, TEA was
performed on 67 (24%), and from these, 56 (84%) were
extubated in the operating theatre. There were 5 cases of
unsatisfactory analgesia and 1 case of accidental removal
of the epidural catheter. Serious complications of TEA
were not reported from any of the patients. The authors
concluded that TEA is a safe component of anaesthesia
in a selected group of patients undergoing OLT that al-
lows early extubation (22). The limitation of the study is
that it was not a randomised controlled trial and did not
compare the outcome benefits of TEA with that of IV
opioids.
The abstract presented at a LiCAGE meeting in 2003
presented a review of the practice at King’s College Hos-
pital, where TEA has been used for LT recipients since
1990 (23). They had 1654 LT recipients (1232 adults and
422 children) between 1990 and 2000. The overall rate of
TEA use was 9.7%; usage was higher in adults (11%)
than in the paediatric population (5.5%). The common-
est cause of liver disease in patients receiving TEA was
primary biliary cirrhosis, followed by primary sclerosing
cholangitis and amyloidosis. Interestingly, the highest
preoperative INR in patients receiving epidural analge-
sia was 4.0, and the lowest platelet count was 32 G/L.
They reported minor complications, namely backache
and inadequate analgesia. The retrospective study, per-
formed 10 years ago in the biggest transplant centre in
the UK, failed to demonstrate the benefits of TEA in LT
recipients in terms of early extubation (23).
TEA in OLT – Our practice
At our centre, TEA has been used on LT adult recipi-
ents for the last 20 years in a carefully selected group of
patients. Our approach, including that towards TEA,
has changed over the last 2 decades in many ways. Our
current practice regarding TEA is as follows: patients
likely to be candidates for TEA receive an oral explana-
tion about TEA, including possible complications, dur-
ing anaesthetic preassessment. They also receive a book-
let about anaesthesia for LT that includes an explanation
of TEA. When we are certain that they understand the
procedure, they sign a written consent form for LT and
anaesthesia, which includes TEA. We use TEA in the se-
lected group of patients with normal preoperative clot-
ting and that we plan to fast track. We ensure that the pa-
tients have an INR of <1.5, APTT of < 45 s, and a
platelet count of >80.000. An experienced anaesthetist
inserts an epidural catheter at the T8–T9 level in a pa-
tient who is awake or asleep. We use remifentanil for
intraoperative analgesia. The epidural catheter is acti-
vated at the end of surgery when a carefully titrated bolus
of 10–20 mL of 0.125% bupivacaine with 2 mg/mL of
fentanyl is administered.
Postoperatively, analgesia is continued with an epi-
dural infusion of 0.125% bupivacaine with 2 mg/mL of
fentanyl at 5–15 mL/h. Pain scores, sensory level, and
haemodynamic parameters determine the rate of the
epidural infusion, which is gradually decreased on daily
basis. Paracetamol is prescribed as background anaesthe-
sia; tramadol is prescribed as a rescue analgesic. If the an-
algesia is inadequate, epidural analgesia is discontinued
and the patient is administered PCA-IV morphine.
The epidural catheter is usually removed on postop-
erative days 3–4, when pain is less intense, and after en-
suring a normal coagulation profile. Tramadol or mor-
phine PCA-IV is used following epidural catheter re-
moval, depending on pain intensity (24).
In conclusion, TEA in OLT may not be the technique
of choice for administration of postoperative analgesia,
but can be considered in patients who have a normal co-
agulation profile preoperatively (e.g. patients with pri-
mary biliary cirrhosis and primary sclerosing cholan-
gitis). The benefits provided by the TEA should be wei-
ghed against the risks of an epidural haematoma.
The safe conduct of TEA in OLT requires anaesthetic
expertise and stringent monitoring in the postoperative
period. Coagulation parameters should be monitored
regularly until after catheter removal. The epidural cath-
eter should be removed only if the coagulation profile is
normal. Alternatively, any residual coagulopathy should
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be corrected with blood products before catheter remo-
val. Frequent neurologic testing should also be carried
out while the epidural catheter is in place and for 12 h af-
ter its removal.
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